Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: China's Exports and Crimea's Crisis Leave Investors Uneasy
Eli Lilly & Co.
View this photo on glassdoor.com
Eli Lilly - The 'Never Say Die' Pharmaceutical
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
China Biotech In Review: iKang Healthcare Planning $150 Million IPO In U.S.
Pipeline Progress at Alkermes - Analyst Blog
Biotech Stock Mailbag: Exact Sciences, Rexahn, Advaxis, Peregrine
Biogen-Eisai Ink Alzheimer's Deal - Analyst Blog
Regulatory Setback for Eli Lilly - Analyst Blog
Teva Up on FDA Nod for Generic Evista - Analyst Blog
FDA spurns Lilly, Boehringer diabetes drug, cites factory problem
Eli Lilly Management Presents at Cowen and Company 34th Annual Health Care Conference (Transcript)